MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.athoracsur.2006.08.010

Медицинская библиотека · The Annals of thoracic surgery · 2007

Multicentered European study on safety and effectiveness of the On-X prosthetic heart valve: intermediate follow-up.

Palatianos George M, Laczkovics Axel M, Simon Paul, Pomar Jose Luis, Birnbaum Dietrich E, Greve Hans H, Haverich Axel

Клиническое исследованиеСтатьяМногоцентровое исследованиеПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

BACKGROUND

This study was performed to determine the safety and effectiveness of the On-X valve, a novel mechanical valve substitute.

METHODS

Eleven centers participated in a European, multicentered, longitudinal, nonrandomized study of the On-X valve performance. Isolated aortic or mitral valve replacement with an On-X valve was studied in 301 patients. Aortic valve replacement was performed in 184 patients (average follow-up, 5.0 years), whereas mitral valve replacement was performed in 117 patients (average follow-up, 4.4 years).

RESULTS

In patients with aortic valve replacement, mean transvalvular pressure gradients ranged from 8.3 to 4.7 mm Hg and effective orifice areas from 1.5 to 2.7 cm2, for 19-mm through 25-mm valves, respectively. After mitral valve replacement, mean gradient was 4.2 mm Hg and effective orifice area by pressure half-time was 2.6 cm2 regardless of valve size. Hemolysis was low, with postoperative serum lactate dehydrogenase at 225 +/- 41 IU (mean +/- standard deviation) or 253 +/- 65 IU, after aortic valve replacement or mitral valve replacement, respectively (upper normal value, 250 IU). At 1 year or greater postoperatively, 91.6% of patients after aortic valve replacement and 84.6% after mitral valve replacement were in New York Heart Association functional class I or II. Adverse event rates in percent per patient-year after aortic valve replacement or mitral valve replacement were thromboembolism, 0.88 or 1.76; thrombosis, 0.11 or 0.20; bleeding, 0.77 or 1.96, respectively. Late mortality was 1.97% or 2.55%, respectively.

CONCLUSIONS

At the intermediate follow-up, the On-X valve exhibited improved hemodynamics, low hemolysis with in-range lactate dehydrogenase, and low adverse event rates, particularly in the aortic position.

Для цитирования: Palatianos George M, Laczkovics Axel M, Simon Paul, Pomar Jose Luis, Birnbaum Dietrich E, Greve Hans H, Haverich Axel. Multicentered European study on safety and effectiveness of the On-X prosthetic heart valve: intermediate follow-up.. The Annals of thoracic surgery. 2007. DOI: 10.1016/j.athoracsur.2006.08.010.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.